Company profilePharmaceutical#502 of 1,318 in Pakistan✓ No DRAP alerts

Lab Diagnostic Systems (SMC) Pvt. Ltd. DSL: 01-374-0006-118530D

Pharmaceutical company · 27 brands · 36 molecules

27 registered products 12 pharmaceutical brands 36 distinct molecules 0 DRAP alerts

Company overview

27
registered products
12
pharmaceutical brands
36
distinct molecules
0
therapeutic classes
0
DRAP alerts

Lab Diagnostic Systems (SMC) Pvt. Ltd. DSL: 01-374-0006-118530D is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 27 product registrations across 36 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Lab

43 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

42
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202542

Top molecules by brand count

Bortezomib ...... 3.5 Mg1 brand
Inactivated Quadrivalent Suspension For Injection ...... 15 Μg1 brand
Erlotinib ...... 150 Mg1 brand
Cisplatin ...... 1 Mg1 brand
Capecitabine ...... 500 Mg1 brand
Ibrutinib ...... 140 Mg1 brand
Imatinib ...... 100 Mg1 brand
Cinitapride Hydrogen ...... 1 Mg1 brand
Lenalidomide ...... 10 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official37 products · Rs 359.16 – Rs 255,816.12
Median across source: Rs 7,244.56

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

MACTER INTERNATIONAL (PVT) LTD. holds 174 molecules not in this portfolio
10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium HydroxideAluminium Hydroxide And Oxide
Merixil Pharma DSL: DHO-ISB-1745 holds 6 molecules not in this portfolio
FilgrastimFilgrastim (Recombinant Human Granulocyte Colony-Stimulating Factor InjectionLeuprorelinOndansetronRhug-Csf)Zoledronic Acid 4Mg

Get the full profile for Lab

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.